Skip to content

DEARGEN UPDATES

Technical & News Articles about Deargen

Press Enter / Return to begin your search.
NEWS2021년 2월 16일2021년 8월 10일

Deargen-Uppthera, co-development of Proteolytic drugs

Deargen, a company specializing in AI new drug development, and Uptera, a new drug development company (TPD), announced on the 16th that they selected two target proteins, including anti-cancer drugs, and signed a joint research contract.

Lead More →

이 글 공유하기:

  • 트위터
  • Facebook

이것이 좋아요:

좋아하기 가져오는 중...
Posted in NEWS and Tagged @Updates href:http://biospectator.com/view/news_view.php?varAtcId=12523 language:english

글 내비게이션

Previous article
Previous articleNEWS디어젠-업테라, AI 활용 ‘단백질 분해약물 공동개발’
Next article
Next articleNEWS디어젠, 아·태 바이오 분석 서비스 톱10 기업 선정
%d 블로거가 이것을 좋아합니다: